DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Boehringer Ingelheim International GmbH. Praxbind® (idarucizumab) Summary of Product Characteristics.
2018 . Available at:
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003986/WC500197462.pdf . Accessed December 12, 2019
Access:
We do not assume any responsibility for the contents of the web pages of other providers.